621 related articles for article (PubMed ID: 16828193)
1. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
[TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses.
Mtiraoui N; Zammiti W; Ghazouani L; Braham NJ; Saidi S; Finan RR; Almawi WY; Mahjoub T
Reproduction; 2006 Feb; 131(2):395-401. PubMed ID: 16452733
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
[TBL] [Abstract][Full Text] [Related]
4. Association of the methylenetetrahydrofolate reductase A1298C but not the C677T single nucleotide polymorphism with sickle cell disease in Bahrain.
Al-Absi IK; Al-Subaie AM; Ameen G; Mahdi N; Mohammad AM; Fawaz NA; Almawi WY
Hemoglobin; 2006; 30(4):449-53. PubMed ID: 16987799
[TBL] [Abstract][Full Text] [Related]
5. Differential contribution of MTHFR C677T variant to the risk of diabetic nephropathy in Lebanese and Bahraini Arabs.
Nemr R; Salman RA; Jawad LH; Juma EA; Keleshian SH; Almawi WY
Clin Chem Lab Med; 2010 Aug; 48(8):1091-4. PubMed ID: 20524928
[TBL] [Abstract][Full Text] [Related]
6. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
[TBL] [Abstract][Full Text] [Related]
7. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet's disease.
Messedi M; Frigui M; Chaabouni Kh; Turki M; Neifer M; Lahiyani A; Messaouad M; Bahloul Z; Ayedi F; Jamoussi K
Gene; 2013 Sep; 527(1):306-10. PubMed ID: 23827456
[TBL] [Abstract][Full Text] [Related]
9. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
Eroglu Z; Erdogan M; Tetik A; Karadeniz M; Cetinalp S; Kosova B; Gunduz C; Ozgen AG; Yilmaz C
Diabetes Metab Res Rev; 2007 Nov; 23(8):621-4. PubMed ID: 17354258
[TBL] [Abstract][Full Text] [Related]
10. [Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy].
Gao CM; Lu JW; Toshiro T; Wu JZ; Cao HX; Chen HQ; Feng JF; Kazuo T
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1054-8. PubMed ID: 15769364
[TBL] [Abstract][Full Text] [Related]
11. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients.
El-Baz R; Settin A; Ismaeel A; Khaleel AA; Abbas T; Tolba W; Abd Allah W; Sobh MA
J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):472-7. PubMed ID: 22554825
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH).
Sazci A; Ergul E; Aygun C; Akpinar G; Senturk O; Hulagu S
Cell Biochem Funct; 2008 Apr; 26(3):291-6. PubMed ID: 17563923
[TBL] [Abstract][Full Text] [Related]
13. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine and methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Tunisian patients with severe coronary artery disease.
Ghazouani L; Abboud N; Mtiraoui N; Zammiti W; Addad F; Amin H; Almawi WY; Mahjoub T
J Thromb Thrombolysis; 2009 Feb; 27(2):191-7. PubMed ID: 18204887
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro- and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus.
Rahimi M; Hasanvand A; Rahimi Z; Vaisi-Raygani A; Mozafari H; Rezaei M; Zargooshi J; Najafi F; Shakiba E
Clin Biochem; 2010 Nov; 43(16-17):1333-9. PubMed ID: 20800057
[TBL] [Abstract][Full Text] [Related]
16. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia.
Vilella E; Virgos C; Murphy M; Martorell L; Valero J; Simó JM; Joven J; Fernández-Ballart J; Labad A
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1169-74. PubMed ID: 16076517
[TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinemia and MTHFR C677T and A1298C polymorphisms are associated with chronic allograft nephropathy in renal transplant recipients.
Pavarino-Bertelli EC; Sanches de Alvarenga MP; Goloni-Bertollo EM; Baptista MA; Haddad R; Hoerh NF; Eberlin MN; Abbud-Filho M
Transplant Proc; 2004 Dec; 36(10):2979-81. PubMed ID: 15686674
[TBL] [Abstract][Full Text] [Related]
18. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
Böger CA; Stubanus M; Haak T; Götz AK; Christ J; Hoffmann U; Riegger GA; Krämer BK
Nephrol Dial Transplant; 2007 Jan; 22(1):154-62. PubMed ID: 17005529
[TBL] [Abstract][Full Text] [Related]
19. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K
Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
